Vecuronium

CHEMBL1201219 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
557.8 g/mol
LogP
6.5
Phase
4

This neuromuscular blocking agent is used during surgery or mechanical ventilation in hospitals to cause temporary paralysis of skeletal muscles, facilitating tracheal intubation and surgical procedures. It works by blocking the neuromuscular junction so that nerve signals cannot trigger muscle contractions. It has no pain-relieving or sedating properties and must always be used alongside appropriate anesthesia.

الوزن الجزيئي

557,8000 g/mol

LogP

6,50

TPSA

55,80 Ų

قاعدة ليبينسكي للخمسة

راسب

المجالات العلاجية

آلية العمل

Blocks neuromuscular transmission at the motor end plate by competing with acetylcholine for nicotinic receptor binding sites, producing skeletal muscle relaxation and paralysis.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Blocks neuromuscular transmission at the motor end plate by competing with acetylcholine for nicotinic receptor binding sites, producing skeletal muscle relaxation and paralysis.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1

InChI

InChI=1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1

Molecular Formula

C34H57N2O4+

HBD / HBA

- / 5

الروابط القابلة للدوران

6

الذرات الثقيلة

40

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This neuromuscular blocking agent is used during surgery or mechanical ventilation in hospitals to cause temporary paralysis of skeletal muscles, facilitating tracheal intubation and surgical procedures. It works by blocking the neuromuscular junction so that nerve signals cannot trigger muscle contractions. It has no pain-relieving or sedating properties and must always be used alongside appropriate anesthesia.

Blocks neuromuscular transmission at the motor end plate by competing with acetylcholine for nicotinic receptor binding sites, producing skeletal muscle relaxation and paralysis.

Yes, Vecuronium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201219. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 39765. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.